Teraplast S.A. (BVB:TRP)
Romania
· Delayed Price · Currency is RON | Market Cap | 1.40B |
| Revenue (ttm) | 1.08B |
| Net Income (ttm) | 1.35M |
| Shares Out | 3.00B |
| EPS (ttm) | 0.00 |
| PE Ratio | 1,036.79 |
| Forward PE | 46.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 570,060 |
| Average Volume | 1,379,288 |
| Open | 0.475 |
| Previous Close | 0.475 |
| Day's Range | 0.468 - 0.475 |
| 52-Week Range | 0.266 - 0.550 |
| Beta | 0.63 |
| RSI | 41.60 |
| Earnings Date | May 13, 2026 |
About Teraplast
Teraplast S.A., together with its subsidiaries, operates as a polymer processor in Romania and internationally. It offers solutions for interior and exterior sewage, water and gas transport and distribution, rainwater management, cable protection, microtubes for telecommunication, and underfloor heating system; plasticized and rigid PVC granules used for various industrial applications, such as electrical cables, extruded, and injected products; and halogen-free, fire-resistant granules. The company also operates as a rigid PVC recycler. In add... [Read more]
Financial Performance
Financial StatementsNews
Teraplast SA (BSE:TRP) Full Year 2025 Earnings Call Highlights: Surpassing Milestones and ...
Teraplast SA (BSE:TRP) Full Year 2025 Earnings Call Highlights: Surpassing Milestones and Navigating Challenges
Full Year 2025 Teraplast SA Earnings Call Transcript
Full Year 2025 Teraplast SA Earnings Call Transcript
Teraplast Earnings Call Transcript: Q4 2025
Turnover grew 21% to RON 1.08 billion in 2025, with EBITDA up 75% and net profit reversing prior losses. Strong international sales and M&A integration drove results, while 2026 targets further growth and improved margins.
Teraplast Earnings Call Transcript: Q3 2025
Turnover rose 26% to RON 857 million and EBITDA grew 59% to RON 72 million, driven by volume growth and M&A. Net profit reached RON 6.3 million, reversing last year's loss, with strong export gains and improved margins despite higher raw material and financial costs.
Teraplast Earnings Call Transcript: Q2 2025
Consolidated sales rose 29% year-over-year to RON 552 million, with EBITDA up 74% and net profit reversing last year's loss, driven by acquisitions and strong infrastructure demand. Packaging remains challenging, but leverage is expected to improve by year-end.
Teraplast Earnings Call Transcript: Q4 2024
Revenue grew 33.5% in 2024, driven by acquisitions and volume growth, but margin pressure led to a net loss. 2025 guidance targets 12% revenue growth, a 69% EBITDA increase, and a return to profitability, with a focus on consolidating recent acquisitions and operational improvements.
Teraplast Earnings Call Transcript: Q3 2024
Turnover rose over 30% year-over-year, driven by acquisitions and volume growth, but EBITDA margins declined and the group posted a net loss due to cost pressures and underperforming segments. Expansion continues with the Optiplast acquisition pending, while cautious optimism is held for 2025.
Teraplast Earnings Call Transcript: Q2 2024
Turnover grew 34% year-over-year in H1 2024, driven by infrastructure demand, M&A, and export expansion. EBITDA rose 15%, but margin declined due to aggressive pricing and integration costs. Net loss resulted from non-recurring items, with positive outlook for H2.